Synergy CHC Valuation
Is SNYR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SNYR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SNYR ($6.02) is trading below our estimate of fair value ($10.36)
Significantly Below Fair Value: SNYR is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SNYR?
Key metric: As SNYR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is SNYR's PE Ratio? | |
|---|---|
| PE Ratio | 10.3x |
| Earnings | US$5.11m |
| Market Cap | US$50.66m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2x |
| Enterprise Value/EBITDA | 8.3x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does SNYR's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 41.1x | ||
UG United-Guardian | 12.9x | n/a | US$44.6m |
NHTC Natural Health Trends | 85.2x | n/a | US$62.9m |
LFVN LifeVantage | 39.9x | n/a | US$162.0m |
MED Medifast | 26.6x | 4.4% | US$193.4m |
SNYR Synergy CHC | 10.3x | n/a | US$50.7m |
Price-To-Earnings vs Peers: SNYR is good value based on its Price-To-Earnings Ratio (10.3x) compared to the peer average (41.1x).
Price to Earnings Ratio vs Industry
How does SNYR's PE Ratio compare vs other companies in the US Personal Products Industry?
| 1 Company | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
NEPT.F Neptune Wellness Solutions | n/a | n/a | US$4.00 |
| 1 Company | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: SNYR is good value based on its Price-To-Earnings Ratio (10.3x) compared to the North American Personal Products industry average (27x).
Price to Earnings Ratio vs Fair Ratio
What is SNYR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 10.3x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SNYR's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Kimberly-Clark
US$45.2b
Manufactures and markets personal care and consumer tissue products in the United States.
KMB
US$136.37
7D
3.2%
1Y
11.5%
Beauty Health
US$200.5m
Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
SKIN
US$1.49
7D
-19.5%
1Y
-33.0%
Kimberly-Clark de México S. A. B. de C. V
Mex$86.7b
Manufactures, distributes, and sells disposable products in Mexico.
KCDM.F
Mex$1.37
7D
-5.8%
1Y
n/a